BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato Y, Ochiai D, Abe Y, Masuda H, Fukutake M, Ikenoue S, Kasuga Y, Shimoda M, Kanai Y, Tanaka M. Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages. Stem Cell Res Ther 2020;11:300. [PMID: 32690106 DOI: 10.1186/s13287-020-01809-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Abe Y, Ochiai D, Sato Y, Kanzaki S, Ikenoue S, Kasuga Y, Tanaka M. Prophylactic Therapy with Human Amniotic Fluid Stem Cells Improves Long-Term Cognitive Impairment in Rat Neonatal Sepsis Survivors. Int J Mol Sci 2020;21:E9590. [PMID: 33339379 DOI: 10.3390/ijms21249590] [Reference Citation Analysis]
2 Li B, Lee C, Cadete M, O'Connell JS, Alganabi M, Lee D, Ganji N, Miyake H, Botts SR, Johnson-Henry KC, Maattanen P, Sherman PM, Pierro A. Amniotic fluid stem cell administration can prevent epithelial injury from necrotizing enterocolitis. Pediatr Res 2021. [PMID: 34561550 DOI: 10.1038/s41390-021-01657-6] [Reference Citation Analysis]
3 Ochiai D, Abe Y, Fukutake M, Sato Y, Ikenoue S, Kasuga Y, Masuda H, Tanaka M. Cell sheets using human amniotic fluid stem cells reduce tissue fibrosis in murine full-thickness skin wounds. Tissue Cell 2021;68:101472. [PMID: 33360545 DOI: 10.1016/j.tice.2020.101472] [Reference Citation Analysis]
4 Chen R, Xie Y, Zhong X, Chen F, Gong Y, Wang N, Wang D. MSCs derived from amniotic fluid and umbilical cord require different administration schemes and exert different curative effects on different tissues in rats with CLP-induced sepsis. Stem Cell Res Ther 2021;12:164. [PMID: 33676566 DOI: 10.1186/s13287-021-02218-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abe Y, Ochiai D, Sato Y, Otani T, Fukutake M, Ikenoue S, Kasuga Y, Tanaka M. Amniotic fluid stem cells as a novel strategy for the treatment of fetal and neonatal neurological diseases. Placenta 2021;104:247-52. [PMID: 33461069 DOI: 10.1016/j.placenta.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kurul S, Fiebig K, Flint RB, Reiss IKM, Küster H, Simons SHP, Voller S, Taal HR. Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research. Pediatr Res 2021. [PMID: 34497356 DOI: 10.1038/s41390-021-01721-1] [Reference Citation Analysis]